Assembly Biosciences Inc (ASMB)
14.72
+0.11
(+0.75%)
USD |
NASDAQ |
May 16, 16:00
14.75
+0.03
(+0.20%)
Pre-Market: 20:00
Assembly Biosciences Cash and Short Term Investments (Quarterly): 112.98M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 112.98M |
December 31, 2023 | 130.25M |
September 30, 2023 | 46.21M |
June 30, 2023 | 59.83M |
March 31, 2023 | 73.02M |
December 31, 2022 | 91.61M |
September 30, 2022 | 108.65M |
June 30, 2022 | 116.69M |
March 31, 2022 | 123.00M |
December 31, 2021 | 146.63M |
September 30, 2021 | 180.90M |
June 30, 2021 | 199.08M |
March 31, 2021 | 214.88M |
December 31, 2020 | 216.41M |
September 30, 2020 | 237.94M |
June 30, 2020 | 226.71M |
March 31, 2020 | 249.13M |
December 31, 2019 | 274.04M |
September 30, 2019 | 156.94M |
June 30, 2019 | 173.81M |
March 31, 2019 | 193.54M |
December 31, 2018 | 218.08M |
September 30, 2018 | 233.94M |
June 30, 2018 | 92.67M |
March 31, 2018 | 109.16M |
Date | Value |
---|---|
December 31, 2017 | 119.95M |
September 30, 2017 | 66.30M |
June 30, 2017 | 75.58M |
March 31, 2017 | 90.92M |
December 31, 2016 | 52.96M |
September 30, 2016 | 58.65M |
June 30, 2016 | 63.55M |
March 31, 2016 | 58.32M |
December 31, 2015 | 67.66M |
September 30, 2015 | 65.80M |
June 30, 2015 | 70.73M |
March 31, 2015 | 96.05M |
December 31, 2014 | 29.09M |
September 30, 2014 | 17.93M |
June 30, 2014 | 21.32M |
March 31, 2014 | 23.64M |
December 31, 2013 | 27.06M |
September 30, 2013 | 32.22M |
June 30, 2013 | 33.49M |
March 31, 2013 | 36.87M |
December 31, 2012 | 20.49M |
September 30, 2012 | 23.56M |
June 30, 2012 | 28.84M |
March 31, 2012 | 31.07M |
December 31, 2011 | 36.98M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
46.21M
Minimum
Sep 2023
274.04M
Maximum
Dec 2019
156.94M
Average
151.78M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 1.823M |
Palatin Technologies Inc | 9.485M |
iBio Inc | 2.788M |
Theriva Biologics Inc | 18.26M |
Oragenics Inc | 3.484M |